Skip to main content
. 2012 Sep 17;7:4995–5005. doi: 10.2147/IJN.S34301

Figure 3.

Figure 3

In vitro release of 3-Chloro-4-[(4-methoxyphenyl)amino]furo[2,3-b] quinoline (PK-L4) from solid lipid nanoparticles (SLNs) with and without polyethylene glycol (PEG) monostearate.

Notes: Phosphate-buffered saline (pH 7.4) containing 1% Pluronic® F 127 was used as the receptor medium. Each value represents the mean ± standard deviation (n = 4).